Cargando…

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron

OBJECTIVES: To investigate temporal trends in incidence and severity of COVID-19 among patients with systemic autoimmune rheumatic diseases (SARDs) from the first wave through the Omicron wave. METHODS: We conducted a retrospective cohort study investigating COVID-19 outcomes among SARD patients sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawano, Yumeko, Patel, Naomi J., Wang, Xiaosong, Cook, Claire E., Vanni, Kathleen M.M., Kowalski, Emily N., Banasiak, Emily P., Qian, Grace, DiIorio, Michael, Hsu, Tiffany Y. T., Weinblatt, Michael E., Todd, Derrick J., Wallace, Zachary S., Sparks, Jeffrey A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238187/ https://www.ncbi.nlm.nih.gov/pubmed/35765565 http://dx.doi.org/10.1101/2022.06.19.22276599

Ejemplares similares

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study
por: Qian, Grace, et al.
Publicado: (2022)

Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study
por: Patel, Naomi J., et al.
Publicado: (2023)

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
por: Qian, Grace, et al.
Publicado: (2023)

Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
por: Vanni, Kathleen MM, et al.
Publicado: (2022)

DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study
por: Di Iorio, Michael, et al.
Publicado: (2022)

Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study
por: Schiff, Abigail E., et al.
Publicado: (2023)

DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study
por: Di Iorio, Michael, et al.
Publicado: (2022)

COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study
por: Patel, Naomi J., et al.
Publicado: (2021)

Predictors of low spike antibody response in patients with systemic rheumatic disease after an initial course of COVID-19 vaccination
por: Whelan, Mary Grace, et al.
Publicado: (2023)

404. Impact of cross-coronavirus humoral immunity in post-acute sequelae of COVID-19 in systemic autoimmune rheumatic diseases patients
por: Herman, Jonathan, et al.
Publicado: (2023)

Coronavirus Disease 2019 Outcomes Among Recipients of Anti‐CD20 Monoclonal Antibodies for Immune‐Mediated Diseases: A Comparative Cohort Study
por: Patel, Naomi J., et al.
Publicado: (2021)

Incident systemic rheumatic disease following COVID-19
por: Hsu, Tiffany Y-T, et al.
Publicado: (2021)

A Roadmap for Investigating Preclinical Autoimmunity Using Patient-Oriented and Epidemiologic Study Designs: Example of Rheumatoid Arthritis
por: Kowalski, Emily N., et al.
Publicado: (2022)

Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study
por: Hsu, Tiffany Y-T, et al.
Publicado: (2021)

Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19
por: Herman, Jonathan D., et al.
Publicado: (2022)

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’
por: D’Silva, Kristin M, et al.
Publicado: (2020)

Understanding Fibroblast Heterogeneity in Form and Function
por: Parker, Jennifer B., et al.
Publicado: (2023)

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: DiIorio, Michael, et al.
Publicado: (2022)

Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study
por: Figueroa-Parra, Gabriel, et al.
Publicado: (2022)

Rheumatic autoimmune diseases in women and midlife health
por: Marder, Wendy, et al.
Publicado: (2015)

Safety of the Zoster Vaccine Recombinant Adjuvanted in Rheumatoid Arthritis and Other Systemic Rheumatic Disease Patients: A Single Center's Experience With 400 Patients
por: Stevens, Emma, et al.
Publicado: (2020)

COVID-19 and Disease-Modifying Anti-rheumatic Drugs
por: D’Silva, Kristin M., et al.
Publicado: (2021)

Novel Artificial Intelligence-Based Approaches for Ab Initio Structure Determination and Atomic Model Building for Cryo-Electron Microscopy
por: DiIorio, Megan C., et al.
Publicado: (2023)

Exploring the Structural Variability of Dynamic Biological Complexes by Single-Particle Cryo-Electron Microscopy
por: DiIorio, Megan C., et al.
Publicado: (2022)

Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
por: Das, Priyam, et al.
Publicado: (2023)

Perceptions and Challenges Experienced by African Physicians When Prescribing Methotrexate for Rheumatic Disease: An Exploratory Study
por: Hitchon, Carol A., et al.
Publicado: (2021)

DENT-seq for genome-wide strand-specific identification of DNA single-strand break sites with single-nucleotide resolution
por: Elacqua, Joshua J., et al.
Publicado: (2021)

SARS-CoV-2 infection among patients with autoimmune rheumatic diseases; comparison between the Delta and Omicron waves in Israel()
por: Bieber, Amir, et al.
Publicado: (2023)

Antibody responses following the surge of SARS-CoV-2 Omicron infection among patients with systemic autoimmune rheumatic diseases
por: Xiang, Nan, et al.
Publicado: (2023)

Vitamin D and Autoimmune Rheumatic Diseases
por: Athanassiou, Lambros, et al.
Publicado: (2023)

Mechanisms of hypertension in autoimmune rheumatic diseases
por: Taylor, Erin B., et al.
Publicado: (2019)

The Recent Outbreak of COVID-19 in China During the Omicron Variant Predominance: Clinical Features and Outcomes in Patients with Autoimmune Inflammatory Rheumatic Diseases
por: Geng, Yan, et al.
Publicado: (2023)

Clinical Experience With a Multidisciplinary Model of Vascular Ultrasound for the Evaluation for Giant Cell Arteritis
por: Tedeschi, Sara K., et al.
Publicado: (2021)

Autoimmune Rheumatic Diseases
por: Anaya, Juan-Manuel, et al.
Publicado: (2014)

SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry
por: Liew, Jean, et al.
Publicado: (2022)

Fifteen days in December: capture and analysis of Omicron-related travel restrictions
por: Schermerhorn, Jordan, et al.
Publicado: (2022)

Methotrexate: who would have predicted its importance in rheumatoid arthritis?
por: Weinblatt, Michael E.
Publicado: (2018)

Rheumatism
por: Rouse, E. S. S.
Publicado: (1856)

Rheumatism
por: Jackson, E. B.
Publicado: (1897)

Why are women predisposed to autoimmune rheumatic diseases?
por: Oliver, Jacqueline E, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_t11badrkm2avgshfa2ln9bi49h